News

According to research report the coagulation analyzers market is projected to reach USD 4.84 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 10.2% from 2016 to 2021.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392

• Siemens AG was the largest player in the global coagulation analyzers market, with a share of 24.7% in 2015. The company has a strong presence in the U.S. and in regions such as Europe and Asia-Pacific. It focuses on product launches and agreements as its key growth strategies.
• Thermo Fisher Scientific, Inc. (U.S.) was the second-largest player in the coagulation analyzers market. The company operates in over 50 countries across North America, Europe, Asia, and Latin America. The company pursues the strategies of agreements and expansions in order to increase its share in the coagulation analyzers market.
• Roche Diagnostics (Switzerland) held the third position in the global coagulation analyzers market. The company focuses on introducing innovative and technologically advanced products in the market.

The coagulation analyzers market is consolidated in nature due to the presence of a few large players. The prominent players in the coagulation analyzers market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).

Coagulation Analyzers Market Dynamics:
Drivers
• Increasing Prevalence of Cardiovascular Diseases and Blood Disorders
• Rising Aging Population
• Development of High-Sensitivity POC Coagulation Testing
• Increasing Laboratory Automation
Restraint
• High Cost of Fully Automated Coagulation Analyzer
Opportunities
• Emerging Markets
Challenges
• Slow Adoption of Advanced Hemostasis Instruments in Emerging Economies

This market is segmented based on product, test, technology, end-users, and regions. The coagulation analyzers market consists of various products that are used by clinical laboratories, hospitals, patient self-testing and others. Based on product, coagulation analyzers market is segmented into clinical laboratory analyzers and PoC testing analyzers. The clinical laboratory analyzers segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Owing to increasing rental agreements, the consumables market is expected to grow in the coming years.

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392

According to the new market research report sterility testing market is expected to reach USD 941.0 Million by 2021 from USD 528.0 Million in 2016, at a CAGR of 12.3% from 2016 to 2021.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208866931

Market Dynamics:
Drivers
• Growth of pharmaceutical & biotechnology companies
• Increasing number of drug launches
• Government support for pharmaceutical and biotechnology industries
• Increasing R&D investment in life sciences
Restraints
• High degree of consolidation, major barrier for new market entrants
• Stringent regulatory frameworks and time-consuming approval processes
Opportunities
• Emerging markets
• Increasingly pharmaceutical outsourcing
Challenges
• Shortage of skilled professionals

Growth in the pharmaceutical and biotechnology industries, increase in the number of new drug launches, and increasing R&D in life science research are the key factors driving the growth of this market. The market is further driven by factors such as increasing government support for pharmaceutical and biotechnology industries.

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the sterility testing market, along with revenue estimates & forecasts and market share analysis.

Pharmaceutical and biological manufacturing
With stringent regulatory controls in place, process monitoring, and quality control are carried out for the entire production chain of pharmaceutical and biopharmaceutical products. In this process, sterility testing is carried out for raw materials, bulk lot release testing, and final product release testing.

Medical Device manufacturing
In the medical device industry, the product sterility test is necessary for ensuring that medical devices are free from viable microorganisms. Some of the important medical devices tested for sterility tests include catheters, needles, orthopedic implants, contact lenses, anesthetic and respiratory equipment, and dental implants.

Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208866931

The major players in the sterility testing market include Merck KGaA (Germany), Charles River Laboratories International, Inc. (U.S.), bioMérieux SA (France), SGS S.A. (Switzerland), Sartorius AG (Germany), WuXi AppTec (China), and Thermo Fisher Scientific, Inc. (U.S.). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

According to research report the vascular imaging market is expected to reach USD 5.95 billion by 2022 from USD 4.35 billion in 2017, at a CAGR of 6.5%. The report covers imaging procedures used to assess blood flow for the effective diagnosis and treatment of various cardiovascular diseases (CVDs).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247188200

The vascular imaging market is consolidated in nature due to the presence of large players. The key players in this market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea), Pie Medical Imaging (Netherlands), CorVascular Diagnostics LLC (U.S.), Evena Medical, Inc. (U.S.), LumedX Healthcare Technologies (U.S.), Xograph Healthcare (U.K.), Mindray Medical International Ltd. (China), Novadaq Technologies Inc. (Canada), Omega Medical Imaging LLC. (U.S.), BK Ultrasound (U.S.), and Piur imaging GmbH (Austria).

• Based on technique, the market is segmented into MRI, CT, ultrasound, nuclear imaging, and X-ray. The MRI segment is expected to dominate the global vascular imaging market throughout the forecast period. The increasing incidence of CVDs and the launch of advanced MRI systems are the key factors driving the growth of this segment.
• Based on applications, the market has been segmented into diagnostic and therapeutic applications. The therapeutic applications segment is expected to register the highest growth during the forecast period primarily due to the growing use of imaging techniques in surgeries & treatments.
• Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and other end users. Currently, hospitals are the largest end users of vascular imaging systems. This end-user segment is also expected to register the highest growth during the forecast period. The increasing prevalence of CVDs (resulting in the increased demand for non-invasive techniques), technological advancements, and rising demand for advanced systems in operating rooms (especially in developed countries across North America and Europe) are the major factors driving the growth of this end-user segment.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=247188200

Major industry players launched innovative products in the recent past and have plans to launch new products and expand across geographies by partnerships and acquisitions. GE Healthcare, Siemens Healthineers, and Toshiba Medical Systems Corporation are identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. Further, these leaders have products for all end users in this segment, have a strong geographical presence, and more importantly focus on continuous product innovations.